India’s U.S. trade framework faces a new tariff test

The United States took final action on July 23, 2026, imposing an additional 10% Section 301 duty on most imports from India, subject to product exemptions. The measure has changed the practical tariff position for Indian exporters while the United States and India continue working toward a broader trade agreement.

India said on July 25 that it would keep engaging with Washington, including on sector-specific issues such as textiles. For businesses, the immediate reality is a changing tariff schedule rather than a settled preferential trade arrangement.

What changed on July 23

The Office of the U.S. Trade Representative said the July 23 measure was a final action under Section 301 of the Trade Act of 1974. USTR said the action responded to findings that 60 economies had failed to impose and effectively enforce prohibitions on imports produced with forced labor.

India was placed in the group subject to a 10% Section 301 duty. The additional duty applies on top of standard U.S. most-favored-nation tariffs, with exemptions for specified products and categories. USTR’s fact sheet says the action covers most imports from the affected countries and directs importers to the Federal Register notice for the full exemption list.

This is separate from the broader reciprocal-tariff framework announced by the two governments in February. The July measure is not merely a proposal awaiting a decision, but it also does not by itself establish the final terms of a bilateral trade agreement.

India’s Commerce Ministry, as reported by Reuters, estimated that about 45% of Indian exports to the United States would remain outside the new tariff’s scope because of product exemptions, while the remaining 55% would face the 10% duty. Those percentages are the Indian government’s assessment, not an independently calculated trade dataset presented in the current record.

Why the February framework is not the final deal

The February 6 U.S.-India joint statement described a framework for an interim agreement. It contemplated an 18% U.S. reciprocal tariff on specified Indian goods, including textiles and apparel, leather and footwear, plastics and rubber, organic chemicals, home décor, artisanal products and certain machinery.

The statement also said that, subject to the successful conclusion of the interim agreement, the United States would remove reciprocal tariffs on a range of products, including generic pharmaceuticals, gems and diamonds, and aircraft parts. It separately referred to negotiated outcomes for generic pharmaceuticals and ingredients depending on a U.S. Section 232 investigation.

The February statement said the two countries would promptly implement the framework and work toward finalizing the interim agreement. But the documents and reporting available for this article do not establish a fully operative, signed interim agreement with a settled tariff schedule. The February announcement is therefore best treated as a negotiating framework whose announced terms remain distinct from completed implementation.

Why pharmaceuticals matter

India’s generic-drug industry is particularly sensitive to changes in U.S. trade policy. Reuters reported that the United States accounted for $9.7 billion, or nearly 38%, of India’s $25.8 billion in pharmaceutical exports in 2025.

India’s Commerce Ministry said products including generic pharmaceuticals were excluded from the July 23 Section 301 duty. That current exclusion should not be confused with possible future pharmaceutical tariffs or with the separate tariff questions described in the February framework. Businesses should continue to watch the applicable U.S. tariff action, product classifications and official customs guidance.

Textiles face a more immediate test

India said it would continue discussions on sector-specific issues, including textiles, as part of negotiations on a bilateral trade pact. Reuters reported that Indian textile and apparel exporters could be disadvantaged against several Asian competitors under the new tariff regime.

The sector is among those expressly identified in the February framework as subject to the contemplated 18% reciprocal tariff. The July 10% Section 301 duty is a separate measure, but together the changing rules increase the importance of the final product schedule and any agreement that follows.

What happens next

Reuters reported on July 22 that a broader U.S.-India trade agreement could be signed in three to four months, citing a senior U.S. official who spoke anonymously. The official described remaining U.S. Section 301 investigations as a procedural obstacle. The timing is an estimate, not a formal bilateral deadline or a confirmed outcome.

Until an agreement is finalized and implemented, Indian exporters and U.S. importers should track the official tariff schedule, exemption lists, Federal Register notices and customs instructions. The practical question is not only whether the headline rate is 10% or 18%, but which rate applies to a specific product, whether an exemption is in force and how the duty interacts with existing tariffs.

The immediate change is that much of India’s merchandise trade with the United States now faces an additional 10% Section 301 duty, while negotiations continue over a broader arrangement. Indian goods therefore do not yet have a stable, final preferential tariff regime in the U.S. market.

Sources

Discover more from Interactive News

Subscribe to get the latest posts sent to your email.